Sabra Health Care REIT Statistics
Total Valuation
SBRA has a market cap or net worth of $5.35 billion. The enterprise value is $7.73 billion.
| Market Cap | 5.35B |
| Enterprise Value | 7.73B |
Important Dates
The last earnings date was Monday, November 2, 2026, after market close.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | Nov 13, 2026 |
Share Statistics
SBRA has 261.96 million shares outstanding. The number of shares has increased by 6.23% in one year.
| Current Share Class | 261.96M |
| Shares Outstanding | 261.96M |
| Shares Change (YoY) | +6.23% |
| Shares Change (QoQ) | +2.99% |
| Owned by Insiders (%) | 1.53% |
| Owned by Institutions (%) | 103.29% |
| Float | 257.84M |
Valuation Ratios
The trailing PE ratio is 72.57 and the forward PE ratio is 29.22. SBRA's PEG ratio is 3.87.
| Price/FFO Ratio | 18.48 |
| Price/AFFO Ratio | 12.78 |
| PE Ratio | 72.57 |
| Forward PE | 29.22 |
| PS Ratio | 5.79 |
| Forward PS | 5.33 |
| PB Ratio | 1.89 |
| P/TBV Ratio | 1.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 13.37 |
| PEG Ratio | 3.87 |
Enterprise Valuation
| EV / Earnings | 108.09 |
| EV / Sales | 8.36 |
| EV / EBITDA | 19.78 |
| EV / EBIT | 45.48 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.53, with a Debt / Equity ratio of 0.86.
| Current Ratio | 1.53 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.86 |
| Debt / EBITDA | 6.24 |
| Debt / FCF | n/a |
| Interest Coverage | 1.46 |
Financial Efficiency
Return on equity (ROE) is 2.51% and return on invested capital (ROIC) is 3.11%.
| Return on Equity (ROE) | 2.51% |
| Return on Assets (ROA) | 1.93% |
| Return on Invested Capital (ROIC) | 3.11% |
| Return on Capital Employed (ROCE) | 3.21% |
| Weighted Average Cost of Capital (WACC) | 6.81% |
| Revenue Per Employee | $15.94M |
| Profits Per Employee | $1.23M |
| Employee Count | 58 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SBRA has paid $1.77 million in taxes.
| Income Tax | 1.77M |
| Effective Tax Rate | 2.42% |
Stock Price Statistics
The stock price has increased by +8.26% in the last 52 weeks. The beta is 0.64, so SBRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.64 |
| 52-Week Price Change | +8.26% |
| 50-Day Moving Average | 19.89 |
| 200-Day Moving Average | 20.06 |
| Relative Strength Index (RSI) | 53.47 |
| Average Volume (20 Days) | 2,753,322 |
Short Selling Information
The latest short interest is 17.88 million, so 6.83% of the outstanding shares have been sold short.
| Short Interest | 17.88M |
| Short Previous Month | 17.72M |
| Short % of Shares Out | 6.83% |
| Short % of Float | 6.94% |
| Short Ratio (days to cover) | 7.59 |
Income Statement
In the last 12 months, SBRA had revenue of $924.30 million and earned $71.51 million in profits. Earnings per share was $0.28.
| Revenue | 924.30M |
| Gross Profit | 458.82M |
| Operating Income | 169.95M |
| Pretax Income | 73.04M |
| Net Income | 71.51M |
| EBITDA | 390.77M |
| EBIT | 169.95M |
| Earnings Per Share (EPS) | $0.28 |
Balance Sheet
The company has $67.65 million in cash and $2.44 billion in debt, with a net cash position of -$2.38 billion or -$9.07 per share.
| Cash & Cash Equivalents | 67.65M |
| Total Debt | 2.44B |
| Net Cash | -2.38B |
| Net Cash Per Share | -$9.07 |
| Equity (Book Value) | 2.84B |
| Book Value Per Share | 10.84 |
| Working Capital | 68.49M |
Cash Flow
In the last 12 months, operating cash flow was $400.58 million and capital expenditures -$726.11 million, giving a free cash flow of -$325.53 million.
| Operating Cash Flow | 400.58M |
| Capital Expenditures | -726.11M |
| Depreciation & Amortization | 225.69M |
| Net Borrowing | n/a |
| Free Cash Flow | -325.53M |
| FCF Per Share | -$1.24 |
Margins
Gross margin is 49.64%, with operating and profit margins of 18.39% and 7.74%.
| Gross Margin | 49.64% |
| Operating Margin | 18.39% |
| Pretax Margin | 7.90% |
| Profit Margin | 7.74% |
| EBITDA Margin | 42.28% |
| EBIT Margin | 18.39% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $1.20, which amounts to a dividend yield of 5.87%.
| Dividend Per Share | $1.20 |
| Dividend Yield | 5.87% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 426.07% |
| FCF Payout Ratio | n/a |
| Buyback Yield | -6.23% |
| Shareholder Yield | -0.36% |
| Earnings Yield | 1.38% |
| FCF Yield | -6.08% |
Analyst Forecast
The average price target for SBRA is $22.71, which is 11.11% higher than the current price. The consensus rating is "Buy".
| Price Target | $22.71 |
| Price Target Difference | 11.11% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 12.24% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |